Comparison of bone tissue properties in mouse models with collagenous and non-collagenous genetic mutations using FTIRI

Bone

Volumn 51, Issue 5, 2012, Pages 920-928

  Coleman, Rhima M ^a   Aguilera, Laura ^b   Quinones, Layla ^b   Lukashova, Lyudamila ^a   Poirier, Christophe ^c   Boskey, Adele ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c INDIANA UNIVERSITY   (United States)

Author keywords

Fourier transform infrared spectroscopy; Microcomputed tomography; Mouse models; Osteogenesis imperfecta

Indexed keywords

COLLAGEN;

ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE FRAGILITY; BONE MINERALIZATION; BONE STRUCTURE; COLLAGEN GENE; CONTROLLED STUDY; CORTICAL BONE; CROSS LINKING; EXTRACELLULAR MATRIX; FEMALE; FRAGILITIS OSSIUM MOUSE; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HISTOLOGY; INFRARED SPECTROSCOPY; MALE; MICRO-COMPUTED TOMOGRAPHY; MOUSE; MOUSE STRAIN; NONHUMAN; OSTEOGENESIS IMPERFECTA MOUSE; OSTEOPENIA; STRAIN DIFFERENCE; TRABECULAR BONE; WILD TYPE;

ANIMALS; BONE DENSITY; COLLAGEN; FEMALE; MALE; MICE; MUTATION; OSTEOGENESIS IMPERFECTA; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY MICROTOMOGRAPHY;

EID: 84867073562     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2012.08.110     Document Type: Article

References (46)

1. Scaramuzzo L., Raffaelli L., Spinelli M.S., Damis G., Maccauro G., Manicone P.F. Orthopaedic and dental abnormalities in osteogenesis imperfecta: a review of the literature. J Biol Regul Homeost Agents 2011, 25:313-321.
2. Kelley B.P., Malfait F., Bonafe L., Baldridge D., Homan E., Symoens S., et al. Mutations in FKBP10 cause recessive osteogenesis imperfecta and Bruck syndrome. J Bone Miner Res 2011, 26:666-672.
3. Marini J.C., Cabral W.A., Barnes A.M. Null mutations in LEPRE1 and CRTAP cause severe recessive osteogenesis imperfecta. Cell Tissue Res 2010, 339:59-70.
4. Chipman S.D., Sweet H.O., McBride D.J., Davisson M.T., Marks S.C., Shuldiner A.R., et al. Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta. Proc Natl Acad Sci U S A 1993, 90:1701-1705.
5. Sillence D.O., Ritchie H.E., Dibbayawan T., Eteson D., Brown K. Fragilitas ossium (fro/fro) in the mouse: a model for a recessively inherited type of osteogenesis imperfecta. Am J Med Genet 1993, 45:276-283.
6. Forlino A., Cabral W.A., Barnes A.M., Marini J.C. New perspectives on osteogenesis imperfecta. Nat Rev Endocrinol 2011, 7:540-557.
7. Nicholls A.C., Osse G., Schloon H.G., Lenard H.G., Deak S., Myers J.C., et al. The clinical features of homozygous alpha 2(I) collagen deficient osteogenesis imperfecta. J Med Genet 1984, 21:257-262.
8. Guenet J.L., Stanescu R., Maroteaux P., Stanescu V. Fragilitas ossium: a new autosomal recessive mutation in the mouse. J Hered 1981, 72:440-441.
9. Muriel M.P., Bonaventure J., Stanescu R., Maroteaux P., Guenet J.L., Stanescu V. Morphological and biochemical studies of a mouse mutant (fro/fro) with bone fragility. Bone 1991, 12:241-248.
10. Aubin I., Adams C.P., Opsahl S., Septier D., Bishop C.E., Auge N., et al. A deletion in the gene encoding sphingomyelin phosphodiesterase 3 (Smpd3) results in osteogenesis and dentinogenesis imperfecta in the mouse. Nat Genet 2005, 37:803-805.
11. Devillard R., Galvani S., Thiers J.C., Guenet J.L., Hannun Y., Bielawski J., et al. Stress-induced sphingolipid signaling: role of type-2 neutral sphingomyelinase in murine cell apoptosis and proliferation. PLoS One 2010, 5:e9826.
12. Chae Y.M., Heo S.H., Kim J.Y., Lee J.M., Ryoo H.M., Cho J.Y. Upregulation of smpd3 via BMP2 stimulation and Runx2. BMB Rep 2009, 42:86-90.
13. Hill P.A., Tumber A. Ceramide-induced cell death/survival in murine osteoblasts. J Endocrinol 2010, 206:225-233.
14. Khavandgar Z., Poirier C., Clarke C.J., Li J., Wang N., McKee M.D., et al. A cell-autonomous requirement for neutral sphingomyelinase 2 in bone mineralization. J Cell Biol 2011, 194:277-289.
15. Boskey A., Mendelsohn R. Infrared analysis of bone in health and disease. J Biomed Opt 2005, 10:031102.
16. Paschalis E.P., Verdelis K., Doty S.B., Boskey A.L., Mendelsohn R., Yamauchi M. Spectroscopic characterization of collagen cross-links in bone. J Bone Miner Res 2001, 16:1821-1828.
17. Pleshko N., Boskey A., Mendelsohn R. Novel infrared spectroscopic method for the determination of crystallinity of hydroxyapatite minerals. Biophys J 1991, 60:786-793.
18. Martin C.J., Axelrod A.E. A modified method for determination of hydroxyproline. Proc Soc Exp Biol Med 1953, 83:461-462.
19. Montford B., Cribbs S.C. Determination of metals in phospholipids by atomic-absorption spectrophotometry. Talanta 1969, 16:1079-1081.
20. Heinonen J.K., Lahti R.J. A new and convenient colorimetric determination of inorganic orthophosphate and its application to the assay of inorganic pyrophosphatase. Anal Biochem 1981, 113:313-317.
21. Cole J.H., van der Meulen M.C. Whole bone mechanics and bone quality. Clin Orthop Relat Res 2011, 469:2139-2149.
22. Fratzl P., Paris O., Klaushofer K., Landis W.J. Bone mineralization in an osteogenesis imperfecta mouse model studied by small-angle x-ray scattering. J Clin Invest 1996, 97:396-402.
23. Fratzl-Zelman N., Morello R., Lee B., Rauch F., Glorieux F.H., Misof B.M., et al. CRTAP deficiency leads to abnormally high bone matrix mineralization in a murine model and in children with osteogenesis imperfecta type VII. Bone 2010, 46:820-826.
24. Gericke A., Qin C., Spevak L., Fujimoto Y., Butler W.T., Sorensen E.S., et al. Importance of phosphorylation for osteopontin regulation of biomineralization. Calcif Tissue Int 2005, 77:45-54.
25. Shapses S.A., Cifuentes M., Spevak L., Chowdhury H., Brittingham J., Boskey A.L., et al. Osteopontin facilitates bone resorption, decreasing bone mineral crystallinity and content during calcium deficiency. Calcif Tissue Int 2003, 73:86-92.
26. Boskey A.L., Spevak L., Paschalis E., Doty S.B., McKee M.D. Osteopontin deficiency increases mineral content and mineral crystallinity in mouse bone. Calcif Tissue Int 2002, 71:145-154.
27. Boskey A.L., Spevak L., Doty S.B., Rosenberg L. Effects of bone CS-proteoglycans, DS-decorin, and DS-biglycan on hydroxyapatite formation in a gelatin gel. Calcif Tissue Int 1997, 61:298-305.
28. Roschger P., Paschalis E.P., Fratzl P., Klaushofer K. Bone mineralization density distribution in health and disease. Bone 2008, 42:456-466.
29. Gourion-Arsiquaud S., Allen M.R., Burr D.B., Vashishth D., Tang S.Y., Boskey A.L. Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity. Bone 2010, 46:666-672.
30. Grabner B., Landis W.J., Roschger P., Rinnerthaler S., Peterlik H., Klaushofer K., et al. Age- and genotype-dependence of bone material properties in the osteogenesis imperfecta murine model (oim). Bone 2001, 29:453-457.
31. Bank R.A., Tekoppele J.M., Janus G.J., Wassen M.H., Pruijs H.E., Van der Sluijs H.A., et al. Pyridinium cross-links in bone of patients with osteogenesis imperfecta: evidence of a normal intrafibrillar collagen packing. J Bone Miner Res 2000, 15:1330-1336.
32. McBride D.J., Choe V., Shapiro J.R., Brodsky B. Altered collagen structure in mouse tail tendon lacking the alpha 2(I) chain. J Mol Biol 1997, 270:275-284.
33. Sricholpech M., Perdivara I., Yokoyama M., Nagaoka H., Terajima M., Tomer K.B., Yamauchi M. Lysyl Hydroxylase 3-mediated Glucosylation in Type I Collagen: MOLECULAR LOCI AND BIOLOGICAL SIGNIFICANCE. J Biol Chem 2012, 287:22998-23009.
34. Donnelly E., Meredith D.S., Nguyen J.T., Gladnick B.P., Rebolledo B.J., Shaffer A.D., Lorich D.G., Lane J.M., Boskey A.L. Reduced cortical bone compositional heterogeneity with bisphosphonate treatment in postmenopausal women with intertrochanteric and subtrochanteric fractures. J Bone Miner Res 2012, 27:672-678.
35. Opsahl S., Septier D., Aubin I., Guenet J.L., Sreenath T., Kulkarni A., et al. Is the lingual forming part of the incisor a structural entity? Evidences from the fragilitas ossium (fro/fro) mouse mutation and the TGFbeta1 overexpressing transgenic strain. Arch Oral Biol 2005, 50:279-286.
36. Gorski J.P. Biomineralization of bone: a fresh view of the roles of non-collagenous proteins. Front Biosci 2011, 17:2598-2621.
37. Raspanti M., Viola M., Forlino A., Tenni R., Gruppi C., Tira M.E. Glycosaminoglycans show a specific periodic interaction with type I collagen fibrils. J Struct Biol 2008, 164:134-139.
38. Vogel K.G., Trotter J.A. The effect of proteoglycans on the morphology of collagen fibrils formed in vitro. Coll Relat Res 1987, 7:105-114.
39. Scott J.E., Haigh M. Identification of specific binding sites for keratan sulphate proteoglycans and chondroitin-dermatan sulphate proteoglycans on collagen fibrils in cornea by the use of cupromeronic blue in 'critical-electrolyte-concentration' techniques. Biochem J 1988, 253:607-610.
40. Goldberg M., Opsahl S., Aubin I., Septier D., Chaussain-Miller C., Boskey A., et al. Sphingomyelin degradation is a key factor in dentin and bone mineralization: lessons from the fro/fro mouse. The chemistry and histochemistry of dentin lipids. J Dent Res 2008, 87:9-13.
41. Gilbert S.J., Blain E.J., Jones P., Duance V.C., Mason D.J. Exogenous sphingomyelinase increases collagen and sulphated glycosaminoglycan production by primary articular chondrocytes: an in vitro study. Arthritis Res Ther 2006, 8:R89.
42. Stoffel W., Jenke B., Holz B., Binczek E., Gunter R.H., Knifka J., et al. Neutral sphingomyelinase (SMPD3) deficiency causes a novel form of chondrodysplasia and dwarfism that is rescued by Col2A1-driven smpd3 transgene expression. Am J Pathol 2007, 171:153-161.
43. Camacho N.P., Hou L., Toledano T.R., Ilg W.A., Brayton C.F., Raggio C.L., et al. The material basis for reduced mechanical properties in oim mice bones. J Bone Miner Res 1999, 14:264-272.
44. Cox L.G., van Rietbergen B., van Donkelaar C.C., Ito K. Analysis of bone architecture sensitivity for changes in mechanical loading, cellular activity, mechanotransduction, and tissue properties. Biomech Model Mechanobiol 2011, 10:701-712.
45. van der Linden J.C., Day J.S., Verhaar J.A., Weinans H. Altered tissue properties induce changes in cancellous bone architecture in aging and diseases. J Biomech 2004, 37:367-374.
46. Rauch F., Travers R., Parfitt A.M., Glorieux F.H. Static and dynamic bone histomorphometry in children with osteogenesis imperfecta. Bone 2000, 26:581-589.